Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

1.96
Delayed Data
As of Dec 12
 -0.1625 / -7.65%
Today’s Change
1.55
Today|||52-Week Range
5.75
-24.52%
Year-to-Date
No recent news for AcelRx Pharmaceuticals Inc.

Today’s Trading

Previous close2.13
Today’s open2.15
Day’s range1.95 - 2.20
Volume867,010
Average volume (3 months)1,687,400
Market cap$107.0M
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-58.33%
Earnings growth (this year)-11.32%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)-9.89%
P/E ratioNM
Price/Sales6.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-1.00-18.69%
MLNTMelinta Therapeutics...+0.35+2.42%
RDHLRedhill Biopharma Lt...-0.03-0.65%
TRVNTrevena Inc-0.12-7.14%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateMarch 13, 2018
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$17.4M
Annual profit (last year)-$43.2M
Net profit margin-248.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Vincent J. Angotti
Chief Financial Officer
Raffi Asadorian
Corporate headquarters
Redwood City, California

Forecasts